TAO Synergies Inc (TAOX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TAOX SEC filings page.
TAO Synergies Inc (TAOX) reported $299K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Development-stage economics are absorbing substantial fixed overhead while early revenue remains too small to support the cost base.
In FY2025, gross profit was only$261K despite an87.2% gross margin, while operating expenses produced a$9.0M operating loss; the constraint is scale, not product-level gross profitability. R&D was just$322K versus$9.0M of SG&A, so the reported loss is primarily an overhead burden rather than a research-spending cycle.
The balance sheet is lightly debt-loaded: FY2025 debt-to-equity was 0.2x, with
The cash-flow pattern points to externally financed investment: FY2025 operating cash outflow was
Financial Health Signals
TAO Synergies Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
TAO Synergies Inc passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
TAO Synergies Inc reported a net loss of $28.7M while operations used $6.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
TAO Synergies Inc generated $89K in revenue in Q2 2026. This represents an increase of 2136.9% from the same quarter a year earlier. Against the prior quarter it is down 77.2%.
TAO Synergies Inc's EBITDA was -$1.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 48.3% from the same quarter a year earlier. Against the prior quarter it is down 19.1%.
TAO Synergies Inc reported -$9.3M in net income in Q2 2026. This represents an increase of 46.9% from the same quarter a year earlier. Against the prior quarter it is down 318.6%.
Cash & Balance Sheet
TAO Synergies Inc held $2.4M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
TAO Synergies Inc's gross margin was 75.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. Against the prior quarter it is down 20.4 percentage points.
TAO Synergies Inc's ROE was -72.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 28.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 91.2 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
TAO Synergies Inc invested $32K in research and development in Q2 2026. This represents a decrease of 78.6% from the same quarter a year earlier. Against the prior quarter it is up 11.4%.
Not reported for Q2 2026.
Not reported for Q2 2026.
TAOX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $89K+2136.9% | $389K | N/A | $203K | $4K | N/A | N/A | N/A |
| Cost of Revenue | $22K | $17K | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $67K | $371K | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $32K-78.6% | $29K-53.0% | N/A | $54K-75.6% | $149K-56.6% | $61K-90.0% | N/A | $223K+5.1% |
| SG&A Expenses | $1.6M-25.8% | $1.7M+66.4% | N/A | $1.9M+71.4% | $2.2M+76.9% | $1.0M-6.8% | N/A | $1.1M-6.6% |
| Operating Income | -$1.6M+48.3% | -$1.3M-23.3% | N/A | -$1.8M+9.0% | -$3.0M-92.0% | -$1.1M | N/A | -$2.0M |
| EBITDA | -$1.6M+48.3% | -$1.3M-23.3% | N/A | -$1.8M+9.0% | -$3.0M-92.1% | -$1.1M | N/A | -$2.0M |
| Income Tax | $0 | $0 | N/A | N/A | $0 | $0 | N/A | N/A |
| Net Income | -$9.3M+46.9% | $4.3M+1004.6% | N/A | -$3.9M+31.7% | -$17.5M-1275.6% | $385K+286.3% | N/A | -$5.7M-852.4% |
| EPS (Basic) | -$1.83+83.7% | $0.45+275.0% | $1.03-76.4% | -$1.56+68.9% | -$11.26-854.2% | $0.12+129.3% | $4.36+158.5% | -$5.01-696.4% |
| EPS (Diluted) | -$1.83 | $0.43 | $1.03 | -$1.56 | -$11.26 | $0.04 | $4.36 | -$5.01 |
| Diluted Shares (Avg) | 7M | 8M | N/A | 3M | 2M | 1M | N/A | 1M |
Not reported in any period shown, so not listed: Interest Expense.
TAOX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.1M+6.6% | $31.0M+102.5% | $25.8M+45.7% | $18.4M-19.6% | $19.8M-30.3% | $15.3M-47.9% | $17.7M-43.0% | $22.8M-29.5% |
| Current Assets | $20.6M+4.2% | $30.2M+97.4% | $25.4M+43.2% | $18.3M-17.6% | $19.8M-28.9% | $15.3M-46.9% | $17.7M-42.0% | $22.3M-31.1% |
| Cash & Equivalents | $2.4M-83.5% | $3.6M-75.4% | $5.5M-68.9% | $1.4M-92.6% | $14.4M-42.5% | $14.8M-43.7% | $17.7M-38.4% | $19.6M-38.1% |
| Short-Term Investments | $0 | $0 | $0 | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $2.4M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $8.4M+357.2% | $4.9M-45.0% | $3.9M-64.1% | $1.7M-82.6% | $1.8M-80.9% | $8.9M+36.2% | $11.0M+98.2% | $9.7M+147.0% |
| Current Liabilities | $1.0M+7.0% | $1.1M+423.9% | $1.8M+78.8% | $1.0M+205.7% | $964K-89.7% | $211K-96.7% | $1.0M-76.3% | $341K-81.2% |
| Non-Current Liabilities | $7.3M+748.5% | $3.8M-56.4% | $2.1M-78.6% | $648K-93.1% | $863K+265.7% | $8.7M+3788.3% | $9.9M+693.5% | $9.4M+343.2% |
| Total Equity | $12.7M-26.1% | $23.3M+350.0% | $21.1M+259.0% | $16.1M+25.5% | $17.2M-8.2% | $5.2M-76.6% | $5.9M-75.9% | $12.8M-52.1% |
| Retained Earnings | -$81.6M-26.6% | -$72.1M-53.9% | -$76.2M-61.5% | -$68.5M-64.9% | -$64.5M-81.9% | -$46.9M-37.8% | -$47.2M-40.3% | -$41.5M-28.2% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
TAOX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$875K-16.8% | -$1.7M+15.9% | -$2.5M-109.9% | -$1.2M-15.9% | -$749K+12.2% | -$2.0M-9.2% | -$1.2M-9.6% | -$1.0M+12.0% |
| Depreciation & Amortization | $735-24.9% | $816-20.9% | $802-31.7% | $803-52.5% | $979-25.7% | $1K-26.2% | $1K-2.9% | $2K-2.0% |
| Stock-Based Compensation | N/A | N/A | N/A | N/A | N/A | $4K-74.3% | N/A | $4K-74.8% |
| Investing Cash Flow | N/A | N/A | -$11.3M | -$13.1M | N/A | N/A | $0+100.0% | $0 |
| Financing Cash Flow | -$402K-108.4% | -$169K+79.4% | $17.8M+2323.7% | $1.3M | $4.8M | -$822K | -$802K-1571849.0% | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
TAOX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.1% | 95.5% | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -1770.6% | -338.9% | N/A | -884.8% | -76623.8% | N/A | N/A | N/A |
| Net Margin | -10492.4% | 1094.3% | N/A | -1929.1% | -442101.9% | N/A | N/A | N/A |
| Return on Equity | -72.9%+28.6pp | 18.3%+10.8pp | N/A | -24.4%+20.4pp | -101.5%-94.8pp | 7.4%+8.4pp | N/A | -44.9%-47.7pp |
| Return on Assets | -44.1%+44.4pp | 13.7%+11.2pp | N/A | -21.4%+3.8pp | -88.5%-84.0pp | 2.5%+3.2pp | N/A | -25.2%-27.5pp |
| Current Ratio | 19.99-0.5x | 27.40-45.3x | 13.99-3.5x | 17.61-47.8x | 20.51+17.5x | 72.71+68.1x | 17.47+10.3x | 65.36+47.6x |
| Debt-to-Equity | 0.66+0.5x | 0.21-1.5x | 0.19-1.7x | 0.11-0.7x | 0.11-0.4x | 1.72+1.4x | 1.87+1.6x | 0.76+0.6x |
| Asset Turnover | 0.000.0x | 0.01 | N/A | 0.01 | 0.00 | N/A | N/A | N/A |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| TAO Synergies Inc TAOX | FY2025 | $299K | -$28.7M | N/A | $29.1M | — |
| Multisensor AI MSAI | FY2025 | $5.6M | -$11.7M | N/A | $10.7M | 38/100 |
| Cloudastructure Inc CSAI | FY2025 | $5.1M | -$8.5M | N/A | $4.3M | 49/100 |
| Bridgeline BLIN | FY2025 | $15.4M | -$2.5M | -16.4% | $11.7M | 37/100 |
| Intrusion INTZ | FY2025 | $7.0M | -$9K | -0.1% | $19.1M | 44/100 |
Where TAO Synergies Inc Ranks
Frequently Asked Questions
What is TAO Synergies Inc's annual revenue?
TAO Synergies Inc (TAOX) reported $299K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is TAO Synergies Inc profitable?
No, TAO Synergies Inc (TAOX) reported a net income of -$28.7M in fiscal year 2025.
What is TAO Synergies Inc's EBITDA?
TAO Synergies Inc (TAOX) had EBITDA of -$9.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is TAO Synergies Inc's gross margin?
TAO Synergies Inc (TAOX) had a gross margin of 87.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is TAO Synergies Inc's return on equity (ROE)?
TAO Synergies Inc (TAOX) has a return on equity of -136.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is TAO Synergies Inc's operating cash flow?
TAO Synergies Inc (TAOX) recorded an outflow of $6.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are TAO Synergies Inc's total assets?
TAO Synergies Inc (TAOX) had $25.8M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does TAO Synergies Inc spend on research and development?
TAO Synergies Inc (TAOX) invested $322K in research and development during fiscal year 2025.
What is TAO Synergies Inc's current ratio?
TAO Synergies Inc (TAOX) had a current ratio of 13.99 as of fiscal year 2025, which is generally considered healthy.
What is TAO Synergies Inc's debt-to-equity ratio?
TAO Synergies Inc (TAOX) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is TAO Synergies Inc's return on assets (ROA)?
TAO Synergies Inc (TAOX) had a return on assets of -111.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is TAO Synergies Inc's P/E ratio?
TAO Synergies Inc (TAOX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $29.1M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is TAO Synergies Inc's price-to-sales ratio?
TAO Synergies Inc (TAOX) trades at 97.2x sales, its market capitalization divided by revenue of $299K revenue, FY2025. The market capitalization is $29.1M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is TAO Synergies Inc's Piotroski F-Score?
TAO Synergies Inc (TAOX) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are TAO Synergies Inc's earnings high quality?
TAO Synergies Inc (TAOX) reported a net loss of $28.7M while operations used $6.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.